Description

Description

Combivair 200/6mcg is a combination respiratory rotacap manufactured by Highnoon Laboratories, a well-established and trusted pharmaceutical company in Pakistan. It brings together an inhaled corticosteroid and a long-acting bronchodilator within a single capsule, designed specifically for inhalation rather than oral swallowing. Compared to the 400/6mcg strength, this version carries a lower dose of the corticosteroid component, making it suitable for patients whose asthma or COPD symptoms are less severe, or for those who are stepping down from a higher-strength combination once their condition is better controlled. This medicine helps reduce airway inflammation while also relaxing the muscles surrounding the airways to make breathing easier. It is not meant for the relief of a sudden asthma attack or acute breathing difficulty. The pack contains 30 rotacaps, intended for continued use with a compatible inhalation device such as a Rotahaler or Revolizer, as directed by a physician.

Ingredients

Each rotacap of Combivair 200/6mcg contains two active pharmaceutical ingredients working together. The first is Budesonide 200mcg, present here at half the strength found in the 400mcg version, a potent glucocorticoid that binds strongly to receptors within the airway tissue, helping to reduce the swelling, irritation, and inflammation that contribute to narrowed airways in asthma and COPD. The second is Formoterol Fumarate 6mcg, a long-acting beta-2 agonist known for its rapid onset of action, which works by relaxing the smooth muscle surrounding the airways, allowing them to widen and making it easier to breathe. Together, these two ingredients address both the underlying airway inflammation and the muscular tightening that contribute to respiratory symptoms, offering a more complete approach to management than either ingredient alone, at a strength suited to milder or well-controlled disease.

Dosage Form

Combivair 200/6mcg is supplied as a rotacap, a capsule containing finely powdered medication intended strictly for inhalation and never for swallowing. The rotacaps are packaged to protect them from light, heat, and moisture, with the full pack containing 30 capsules in total. Each capsule is designed to be used with a compatible inhalation device, such as a Rotahaler or Revolizer, which pierces the capsule and allows the powdered medicine to be drawn into the lungs as the patient inhales.

Uses

Combivair 200/6mcg is primarily used for the regular, ongoing treatment of asthma in patients who require both an inhaled corticosteroid and a long-acting bronchodilator to keep their symptoms under control, particularly those with milder disease or who are being stepped down from a higher-strength combination. It is also used in the management of chronic obstructive pulmonary disease, helping to reduce the frequency of flare-ups and improve overall breathing capacity over time. By combining an anti-inflammatory agent with a bronchodilating agent in one device, this medicine supports more consistent day-to-day symptom control, reducing the likelihood of wheezing, chest tightness, and shortness of breath. It is important to note that this medicine is intended for regular, scheduled use as part of a maintenance treatment plan, and is not suitable for treating a sudden asthma attack or acute episode of breathlessness, for which a separate fast-acting reliever inhaler is generally required.

How To Use

Combivair 200/6mcg should only be used exactly as directed by a registered physician, and always with a compatible inhalation device such as a Rotahaler or Revolizer, since the rotacap itself must never be swallowed. To use it, the capsule is placed into the device’s chamber, where it is pierced, and the patient inhales through the mouthpiece to draw the powdered medicine into the lungs. It is generally recommended to rinse the mouth with water after each use, without swallowing the water, to help reduce the risk of oral thrush and hoarseness that can sometimes occur with inhaled corticosteroids. The device should be used at the same times each day as instructed by the doctor to help maintain steady control of symptoms. If a dose is missed, it should be taken as soon as remembered unless it is close to the time of the next dose, in which case the missed one should simply be skipped rather than doubled. This medicine should not be stopped abruptly without medical advice, even if symptoms improve, since ongoing use is generally necessary to maintain control of the underlying condition.

Side Effects

Combivair 200/6mcg may cause side effects in some patients, though many people tolerate it well, and the lower corticosteroid strength may make certain steroid-related effects somewhat less pronounced than with higher-dose versions. Commonly reported effects include throat irritation, hoarseness, headache, and oral thrush, a fungal infection in the mouth that can often be reduced by rinsing the mouth after each use. Some patients may also notice a mild tremor, palpitations, or a faster heartbeat, particularly when treatment is first started, related to the bronchodilator component. Less commonly, muscle cramps or nervousness may occur. Any signs of a serious allergic reaction, such as swelling of the face or throat, severe rash, or difficulty breathing, require immediate medical attention. Because this medicine combines two active agents, physicians should remain alert for signs of respiratory infection, including pneumonia, particularly in patients with COPD, since some symptoms can overlap with a worsening of the underlying condition.

Pregnancy & Breastfeeding

Combivair 200/6mcg should be used with caution during pregnancy and only under the supervision of a healthcare provider, who will weigh the potential benefits of controlling respiratory symptoms against any possible risks to the developing baby. Women who are pregnant, believe they may be pregnant, or are planning to conceive should discuss their asthma or COPD management with their doctor to ensure the safest possible approach is taken. Similarly, this medicine should only be used while breastfeeding under medical guidance, as both ingredients may pass into breast milk in small amounts, and a doctor can help determine whether continued use is appropriate for the individual situation.

Storage Instructions

Combivair 200/6mcg rotacaps should be stored below 30°C, protected from light, heat, and moisture. The capsules should be kept in their original packaging until they are ready to be used, and the medicine should always be stored well out of the reach and sight of children. Rotacaps should not be used once the expiry date printed on the packaging has passed.

FAQS

Q: How does this strength differ from Combivair 400/6mcg?
This version contains half the budesonide dose, making it suited to milder asthma or COPD, or for patients being stepped down from a higher-strength combination, while the formoterol dose stays the same.

Q: Can Combivair rotacaps be swallowed like a regular capsule?
No, these rotacaps must never be swallowed; they are specifically designed for inhalation using a compatible device such as a Rotahaler or Revolizer.

Q: Can this medicine be used to treat a sudden asthma attack?
No, Combivair is intended for regular, scheduled maintenance treatment and is not suitable for relieving an acute asthma attack, which requires a separate fast-acting reliever inhaler.

Q: What should be done if a dose is missed?
The missed dose should be taken as soon as it is remembered, unless it is close to the time of the next scheduled dose, in which case it should simply be skipped rather than doubled.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.